Phase I Study to Assess the Safety, Tolerability, and Pharmacokinetics of Orally Administered CUDC-101 in Cancer Patients
Clinical trial NCT01702285 · TERMINATED
Trial details
- NCT number
- NCT01702285
- Sponsor
- Curis, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2012-12-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.